Blood-based biomarkers for traumatic brain injury (TBI) have been investigated and
proposed for decades, yet the current clinical assessment of TBI is largely based on clinical …

Nonadherence to prescribed pharmacotherapy is an understated public health problem
globally and is costing many patients their chance to return to good health and healthcare …

While the evidence for urine drug testing for patients on chronic opioid therapy is weak, the
guidelines created by numerous medical societies and state and federal regulatory …

Urine drug testing by immunoassay is widely used to detect nonmedical drug use and to
monitor patients prescribed controlled substances. A key attribute of urine drug testing …

Background Substance use during pregnancy is common, as is biological testing that is
intended to help identify prenatal exposures. However, there is no standardized requirement …

Urine drug testing (UDT) has become an essential component in the management of
patients prescribed opioid analgesics for the treatment of chronic non-malignant pain …

Background Opiates/opioids and benzodiazepines are commonly prescribed drug therapies
for acute and chronic pain. Urine drug testing is often employed to assess adherence to …

Aims Buprenorphine is effective at reducing relapse to opioid misuse, morbidity and
mortality in opioid‐dependent patients. Urine drug screening (UDS) to assess adherence is …

Background Broad-spectrum drug screening is offered by many clinical laboratories to
support investigation of possible drug exposures. The traditional broad-spectrum drug …

Background The direct detection of drugs and metabolites in urine using a targeted panel
offers sensitive and specific detection in comparison to the traditional approach to urine drug …